Search clinical trials for: Placebo for dapagliflozin
Total 69755 results
-
AstraZenecaCompletedType 1 Diabetes MellitusJapan
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2United States
-
Hiddo Lambers HeerspinkAstraZenecaUnknownChronic Kidney Diseases | ProteinuriaCanada, Malaysia, Netherlands
-
Maastricht UniversityAstraZenecaCompletedPrediabetic State | Substrate OxidationNetherlands
-
Klinikum NürnbergRecruitingChronic Renal Failure | Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte HomeostatisGermany, France
-
Rehab WeridaUniversity of AlexandriaRecruitingType 2 Diabetes | Nonalcoholic Fatty Liver DiseaseEgypt
-
Janssen-Cilag International NVCompleted
-
Materia Medica HoldingCompletedAcute Upper Respiratory InfectionsRussian Federation
-
Saint Luke's Health SystemCompletedChronic Heart Failure With Reduced Systolic FunctionUnited States
-
AstraZenecaRecruitingChronic Kidney Disease and HypertensionSpain, United States, Argentina, Denmark, Italy, Sweden, Belgium, France, Turkey, China, Germany, Saudi Arabia, Thailand, Vietnam, Australia, United Kingdom, Serbia, Brazil, Canada, Japan, Malaysia, Philippines, Poland, Taiwan, Greece, Is... and more
-
University Health Network, TorontoRecruitingType 2 Diabetes | Kidney Transplant Recipients | Post-transplant Diabetes MellitusCanada
-
University of Texas Southwestern Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity, VisceralUnited States
-
Sichuan Academy of Medical SciencesRecruitingPeritoneal Dialysis Complication | Renal Function Aggravated | Sodium-glucose Co-transporter-2 InhibitorsChina
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
AstraZenecaTerminatedType 2 Diabetes MellitusThailand, Vietnam
-
Post Graduate Institute of Medical Education and...Not yet recruitingNon-Alcoholic Fatty Liver Disease | Hepatic Steato-FibrosisIndia
-
The University of Hong KongResearch Grant CouncilRecruitingCirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 InhibitorsHong Kong
-
Brigham and Women's HospitalPatient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...Active, not recruitingType2 Diabetes | Renal Disease | Cardiovascular EventsUnited States
-
G.Gennimatas General Hospital2nd Department of Cardiology, "Attikon" University Hospital, National and...Not yet recruitingAcute Kidney Injury | Percutaneous Coronary Intervention | Left Cardiac Catheterization | Sodium-glucose Co-transporter 2 InhibitorsGreece
-
University of WashingtonAstraZenecaCompletedMyocardial Fibrosis | Type 2 Diabetes Mellitus | Myocardial InflammationUnited States
-
Hospices Civils de LyonWithdrawnEnd-stage Heart FailureFrance
-
University of VirginiaRecruitingMyocardial IschemiaUnited States
-
Mansoura UniversityActive, not recruitingLupus Nephritis | SLE | SGLT2 InhibitorsEgypt
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic Control | High HbA1c LevelCzech Republic, Poland, Spain, Germany, Canada, Slovakia
-
Anita SarafThe Pittsburgh FoundationNot yet recruitingHeart Failure | Adult Congenital Heart DiseaseUnited States
-
EMSNot yet recruiting
-
Medical University of ViennaRecruitingReperfusion Injury | Vascular ComplicationsAustria
-
LG ChemUnknown
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States
-
National Medical Research Center for Cardiology...RecruitingHeart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure With Mid Range Ejection Fraction | Amyloid CardiomyopathyRussian Federation
-
AstraZenecaCompletedType 2 Diabetes Mellitus, CKD and AlbuminuriaUnited States, Spain, Canada, Korea, Republic of, Mexico, Japan, Taiwan, Australia, South Africa
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Brazil
-
University of RochesterAstraZenecaCompleted
-
Mansoura UniversityActive, not recruitingLupus Nephritis | BMD | SGLT2 INHIBITORSEgypt
-
AstraZenecaParexel; PRA Health Sciences; Q2 Solutions; Covance Laboratories, IncCompletedType 2 DiabetesUnited States, Israel, Hungary, Russian Federation, Mexico, Romania, United Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2United States
-
The University of Texas Health Science Center at...Janssen Scientific Affairs, LLCWithdrawnCardiovascular Diseases | Type2 Diabetes MellitusUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan
-
University of Colorado, DenverRecruitingVascular Diseases | Diabetes | Kidney Transplant; ComplicationsUnited States
-
University of OklahomaRecruitingDiabetes Mellitus | Atrial FibrillationUnited States
-
Andrea GiaccariRecruitingType2 Diabetes Mellitus | Stable Coronary Artery DiseaseItaly
-
University of PennsylvaniaAmgenCompleted
-
Mansoura UniversityCompletedAcute Heart FailureEgypt
-
Yonsei UniversityCompletedType 2 Diabetes MellitusKorea, Republic of
-
AstraZenecaBristol-Myers SquibbCompleted
-
LM Diagnósticos S.L.AstraZenecaUnknown
-
University Medical Center GroningenAstraZenecaEnrolling by invitationChronic Kidney DiseasesNetherlands, Canada, United States, Denmark, United Kingdom
-
AstraZenecaBristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study GroupCompletedDiabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular EventUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
-
Alexandria UniversityRecruiting